These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

75 related items for PubMed ID: 2319257

  • 21. Interleukin 15 induction of lymphokine-activated killer cell function against autologous tumor cells in melanoma patient lymphocytes by a CD18-dependent, perforin-related mechanism.
    Gamero AM, Ussery D, Reintgen DS, Puleo CA, Djeu JY.
    Cancer Res; 1995 Nov 01; 55(21):4988-94. PubMed ID: 7585540
    [Abstract] [Full Text] [Related]

  • 22. Generation of human lymphokine-activated killer cells following an IL-2 pulse in elderly cancer patients.
    Provinciali M, Di Stefano G, Stronati S, Fabris N.
    Cytokine; 1998 Feb 01; 10(2):132-9. PubMed ID: 9512903
    [Abstract] [Full Text] [Related]

  • 23. Generation of lymphokine-activated killer cell activity from human thymocytes.
    Ramsdell FJ, Golub SH.
    J Immunol; 1987 Sep 01; 139(5):1446-53. PubMed ID: 2442246
    [Abstract] [Full Text] [Related]

  • 24. IL-4 inhibits IL-2-mediated induction of human lymphokine-activated killer cells, but not the generation of antigen-specific cytotoxic T lymphocytes in mixed leukocyte cultures.
    Spits H, Yssel H, Paliard X, Kastelein R, Figdor C, de Vries JE.
    J Immunol; 1988 Jul 01; 141(1):29-36. PubMed ID: 2454260
    [Abstract] [Full Text] [Related]

  • 25. Augmentation of lymphokine-activated killer cell cytotoxicity by monoclonal antibodies against human small cell lung carcinoma.
    Tong AW, Lee JC, Wang RM, Ordonez G, Stone MJ.
    Cancer Res; 1989 Aug 01; 49(15):4103-8. PubMed ID: 2545333
    [Abstract] [Full Text] [Related]

  • 26. IL-4 regulation of murine lymphokine-activated killer activity in vitro. Effects on the IL-2-induced expansion, cytotoxicity, and phenotype of lymphokine-activated killer effectors.
    Mulé JJ, Krosnick JA, Rosenberg SA.
    J Immunol; 1989 Jan 15; 142(2):726-33. PubMed ID: 2783444
    [Abstract] [Full Text] [Related]

  • 27. Interleukin 2 induces human acute lymphocytic leukemia cells to manifest lymphokine-activated-killer (LAK) cytotoxicity.
    Kaufmann Y, Levanon M, Davidsohn J, Ramot B.
    J Immunol; 1987 Aug 01; 139(3):977-82. PubMed ID: 3496395
    [Abstract] [Full Text] [Related]

  • 28. IL-4-induced lymphokine-activated killer cells. Lytic activity is mediated by phenotypically distinct natural killer-like and T cell-like large granular lymphocytes.
    Peace DJ, Kern DE, Schultz KR, Greenberg PD, Cheever MA.
    J Immunol; 1988 May 15; 140(10):3679-85. PubMed ID: 2896213
    [Abstract] [Full Text] [Related]

  • 29. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation.
    Lowdell MW, Shamim F, Hamon M, Macdonald ID, Prentice HG.
    Exp Hematol; 1995 Dec 15; 23(14):1530-4. PubMed ID: 8542943
    [Abstract] [Full Text] [Related]

  • 30. Protein A potentiates lymphokine-activated killer cell induction in normal and melanoma patient lymphocytes.
    Singh KP, Shau H, Gupta RK, Kopald K, Ray PK.
    Immunopharmacol Immunotoxicol; 1992 Dec 15; 14(1-2):73-103. PubMed ID: 1597662
    [Abstract] [Full Text] [Related]

  • 31. Distinct phenotypic and functional characteristics of human natural killer cells obtained by rapid interleukin 2-induced adherence to plastic.
    Vujanovic NL, Rabinowich H, Lee YJ, Jost L, Herberman RB, Whiteside TL.
    Cell Immunol; 1993 Oct 01; 151(1):133-57. PubMed ID: 8402925
    [Abstract] [Full Text] [Related]

  • 32. In vivo induction of lymphokine-activated killer cells by interleukin-2 splenic artery perfusion in advanced malignancy.
    Klasa RJ, Silver HK, Kong S.
    Cancer Res; 1990 Aug 15; 50(16):4906-10. PubMed ID: 2379154
    [Abstract] [Full Text] [Related]

  • 33. Major histocompatibility complex-unrestricted cytolytic activity of human T cells. Analysis of precursor frequency and effector phenotype.
    Patel SS, Thiele DL, Lipsky PE.
    J Immunol; 1987 Dec 01; 139(11):3886-95. PubMed ID: 3500232
    [Abstract] [Full Text] [Related]

  • 34. Isolation and characterization of cytotoxic granules from human lymphokine (interleukin 2) activated killer cells.
    Lowrey DM, Hameed A, Lichtenheld M, Podack ER.
    Cancer Res; 1988 Aug 15; 48(16):4681-8. PubMed ID: 3260817
    [Abstract] [Full Text] [Related]

  • 35. In vitro generation of human activated lymphocyte killer cells: separate precursors and modes of generation of NK-like cells and "anomalous" killer cells.
    Burns GF, Triglia T, Werkmeister JA.
    J Immunol; 1984 Sep 15; 133(3):1656-63. PubMed ID: 6611374
    [Abstract] [Full Text] [Related]

  • 36. The expression and functional involvement of laminin-like molecules in non-MHC restricted cytotoxicity by human Leu-19+/CD3- natural killer lymphocytes.
    Schwarz RE, Hiserodt JC.
    J Immunol; 1988 Nov 15; 141(10):3318-23. PubMed ID: 3263421
    [Abstract] [Full Text] [Related]

  • 37. Lymphokine-activated killer cells in rats: analysis of tissue and strain distribution, ontogeny, and target specificity.
    Vujanovic NL, Herberman RB, Hiserodt JC.
    Cancer Res; 1988 Feb 15; 48(4):878-83. PubMed ID: 3257411
    [Abstract] [Full Text] [Related]

  • 38. Human recombinant IL-4 suppresses the induction of human IL-2 induced lymphokine activated killer (LAK) activity.
    Brooks B, Rees RC.
    Clin Exp Immunol; 1988 Nov 15; 74(2):162-5. PubMed ID: 3265652
    [Abstract] [Full Text] [Related]

  • 39. Induction of human lymphokine-activated killer cells by IFN-alpha and IFN-gamma.
    Ellis TM, McKenzie RS, Simms PE, Helfrich BA, Fisher RI.
    J Immunol; 1989 Dec 15; 143(12):4282-6. PubMed ID: 2512355
    [Abstract] [Full Text] [Related]

  • 40. Lymphokine-activated killer cells in rats. IV. Developmental relationships among large agranular lymphocytes, large granular lymphocytes, and lymphokine-activated killer cells.
    Maghazachi AA, Vujanovic NL, Herberman RB, Hiserodt JC.
    J Immunol; 1988 Apr 15; 140(8):2846-52. PubMed ID: 3258622
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.